: What are some key issues when using beta-blockers in heart failure?
《国际循环》:β受体阻滞剂治疗心衰的情况如何?有哪些需要注意的地方?
Prof. Jessup : The data still says that physicians are not increasing the beta-blockers to their target level. It is easy to keep patients on a very low dose and we all must continue to try to push up the doses of beta-blockers and use evidence-based beta-blockers.
Jessup教授:数据显示,医生在应用β受体阻滞剂时没有用到目标剂量。只用小剂量的β受体阻滞剂容易做到,但是我认为应当尝试增加β受体阻滞剂的剂量,依据循证医学证据来应用β受体阻滞剂。
上一页 [1] [2] [3] [4] 下一页
网友评论仅供其表达个人看法,并不表明国际循环同意其观点或证实其描述。 发表评论需登陆